Previous studies in our laboratory have demonstrated the ability of mo
noaminergic transplants in the rat frontal cortex to produce antidepre
ssive activity in both the learned helplessness model and the forced s
wimming test, as well as to increase monoamine levels in the implanted
frontal cortex. These findings implicate increased cortical levels of
norepinephrine (NE) and serotonin (5-HT) in the antidepressive activi
ty of monoaminergic transplants. The goal of the present study was to
characterize the pharmacologic mechanisms involved in the monoaminergi
c graft-induced antidepressive activity. Immobility scores in the forc
ed swimming test (FST) were assessed after transplantation of 5-HT-con
taining pineal gland tissue, NE-containing adrenal medullary tissue, a
combination of both tissues, or sciatic nerve (control) into the rat
frontal cortex and compared to non-transplanted and chronic imipramine
-treated rats. Monoaminergic transplants and imipramine treatment sign
ificantly reduced immobility scores in the FST in contrast to control
transplanted or untreated animals. All groups were assessed pharmacolo
gically with the adrenergic antagonists phentolamine (alpha) and propr
anolol (beta), and serotonergic antagonists metergoline (5-HT1/5-HT2)
and pirenperone (5-HT2). Serotonergic antagonists, particularly the 5H
T(2) antagonist, blocked the reduction in FST immobility induced by th
e pineal implants. Adrenergic antagonists not only blocked FST immobil
ity reductions in adrenal medullary grafted animals, but overcompensat
ed for the adrenal transplants, producing a large increase in immobili
ty. The FST reduction induced by pineal and adrenal cografts was block
ed by all four monoaminergic antagonists. FST immobility scores in con
trol transplanted and non-transplanted animals were not altered by any
of the antagonists. The immobility reduction produced by chronic imip
ramine treatment was blocked significantly only by propranolol. These
results indicate that adrenal medullary and pineal transplants produce
sustained antidepressive activity via local interaction with alpha-an
d beta-adrenergic receptors or 5HT(2), receptors, respectively, and ma
y be mediated by mechanisms distinct from antidepressant drugs.